A detailed history of Moran Wealth Management, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Moran Wealth Management, LLC holds 29,946 shares of EXEL stock, worth $1.01 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,946
Previous 18,827 59.06%
Holding current value
$1.01 Million
Previous $423,000 83.69%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$21.96 - $27.6 $244,173 - $306,884
11,119 Added 59.06%
29,946 $777,000
Q2 2024

Aug 13, 2024

BUY
$20.34 - $23.73 $141,749 - $165,374
6,969 Added 58.77%
18,827 $423,000
Q1 2024

May 15, 2024

BUY
$20.17 - $23.93 $239,175 - $283,761
11,858 New
11,858 $281,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Moran Wealth Management, LLC Portfolio

Follow Moran Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moran Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moran Wealth Management, LLC with notifications on news.